Showing results (11-20 of 192) with videos related to
Sort By:
Pageof 20
Therapeutic Advances in Medical Oncology|July 27, 2011
Renal cell carcinoma bone metastases: clinical advancesChakshu Sahi, Jennifer J Knox, Mark Clemons, et al.Clinical Nuclear Medicine|October 9, 2015
18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry StudyAmit Singnurkar, Jonathan Wang, Anthony M Joshua, et al.Journal for Immunotherapy of Cancer|December 18, 2014
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanomaJoshua S Manusow, Leila Khoja, Nataly Pesin, et al.Endocrine-Related Cancer|November 8, 2024
Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancerSamuel P G Rollin, Mitchell G Lawrence, Anthony M Joshua, et al.European Urology|December 14, 2025
Beyond Menopause: Ending the Inequality-Why Men with Prostate Cancer Still Lack Therapies for Hot FlushesMartino Pedrani, Silke Gillessen, Erik Briers, et al.Journal for Immunotherapy of Cancer|August 20, 2015
PembrolizumabLeila Khoja, Marcus O Butler, S Peter Kang, et al.Melanoma Research|June 8, 2015
A phase 2 study of tremelimumab in patients with advanced uveal melanomaAnthony M Joshua, Jose G Monzon, Catalin Mihalcioiu, et al.Plos One|February 3, 2017
Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Bethany Pitcher, Leila Khoja, Robert J Hamilton, et al.Journal of the American Academy of Dermatology|October 29, 2021
BRAF inhibition and the spectrum of granulomatous reactionsJames P Pham, Phoebe Star, Kevin Phan, et al.Anticancer Research|September 16, 2016
The Utility of Serum CA9 for Prognostication in Prostate CancerAlan D Smith, Mathew Truong, Rob Bristow, et al.Pageof 20